Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 3/2005

01-08-2005 | Original article

Indications for gastrectomy after incomplete EMR for early gastric cancer

Authors: Hideki Nagano, Shigekazu Ohyama, Tetsu Fukunaga, Yasuyuki Seto, Junko Fujisaki, Toshiharu Yamaguchi, Noriko Yamamoto, Yo Kato, Akio Yamaguchi

Published in: Gastric Cancer | Issue 3/2005

Login to get access
Metadata
Title
Indications for gastrectomy after incomplete EMR for early gastric cancer
Authors
Hideki Nagano
Shigekazu Ohyama
Tetsu Fukunaga
Yasuyuki Seto
Junko Fujisaki
Toshiharu Yamaguchi
Noriko Yamamoto
Yo Kato
Akio Yamaguchi
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2005
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-005-0328-5

Other articles of this Issue 3/2005

Gastric Cancer 3/2005 Go to the issue

Case report

Aggressive G-CSF-producing gastric cancer complicated by lung and brain abscesses, mimicking metastases

Original article

Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen

Case report

Metastatic breast cancer presenting as linitis plastica of the stomach

Case report

Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor

Editorial

Laparoscopic surgery for GIST: too soon to decide

Original article

Risk factors for pancreas-related abscess after total gastrectomy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits